Participate in Research

PROST Study for Occlusive Stroke Treatment
Protocol: SITE00000118
Full Title
pRESET for Occlusive Stroke Treatment
Description
This study enrolls adults who are hospitalized for acute ischemic stroke. The purpose of this study is to learn how safe and effective the pRESET Thrombectomy Device is for the treatment of this condition and for removing the blood clot.

You will be in this study for about 3 months after you have your procedure. During the procedure, either the pRESET or the market approved Solitaire device will be used to treat your blood clot. You will be randomized (like the flip of a coin) to have one of the two devices. After your procedure, you will have 2 study visits in-person and others by phone. Study takes place at BUffalo General Hospital and gates Vascular Institute (875 Ellicott St. Buffalo, NY 14203).
Compensation: No
Eligibility
Adults ages 18+.
Currently admitted to the hospital for an acute ischemic stroke that began in the last 8 hours.
Age Group: Adults
ClinicalTrials.gov: Open Study
Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Thank you for your interest. This study has restricted recruiting for participants and is not accepting inquiries at this time. If you are interested in learning more about studies at UB, you can sign up for the Buffalo Research Registry.
Study teams can login to review submissions